Cardiol Therapeutics Investor Relations Material

Cardiol Therapeutics Inc. is a biopharmaceutical company focused on developing anti-inflammatory and anti-fibrotic therapies for cardiovascular diseases. The company specializes in small molecule therapeutics targeting conditions such as acute myocarditis, heart failure, and other inflammatory heart disorders. The company is headquartered in Oakville, Ontario, Canada, and its shares are listed on the NASDAQ and TSX.